At Synapse Medicine, we believe in medication success, and are dedicated to creating the technology that makes it possible for everyone. To achieve this goal, we have built an extensive global knowledge base for medication using algorithms to ensure the most reliable, up-to-date data. On the front-end, Synapse Medicine provides a SaaS platform and UI components that are used to prescribe, dispense, and manage medications across the entire patient journey. Synapse is working with world-leading hospitals and digital health companies in the United States, Europe, and Japan to transform today’s medication regimens into tomorrow’s medication success.
$28M sweet spot round size
2017
$28M
from 2 investors over 1 rounds
Synapse Medicine raised $28M on March 28, 2022
Investors: Korelya Capital and + 3 Other investors